Lawmakers in Congress released their remaining funding bills meant to avoid a government shutdown after Jan. 30.

Find insight on GSK’s acquisition of RAPT Therapeutics, Novartis and more in the latest Market Talks covering Health Care.

Throughout 2025, Congress introduced several bills related to the pharmacy benefit management (PBM) industry. As with the 118th Congress in 2024 ...

Neurotech says US regulatory changes could spur its efforts to develop medicinal cannabis treatments for childhood ...

OGN wins FDA approval to extend NEXPLANON use to five years, backed by trials showing no pregnancies and strong efficacy ...

An Adopt-A-Highway Interest and Safety meeting will be held at 5:30 p.m. followed by Aiken County Trash Talk at 6:45 p.m.

GlaxoSmithKline (GSK) has agreed to acquire Rapt Therapeutics for $2.2 billion, the companies said today, in a deal intended to bolster the buyer’s pipeline with Rapt’s ozureprubart (RPT904), a ...

Rally Opposing Drastic Cuts to HIV/AIDS Care by Florida Department of Health Over 100 healthcare advocates representing a coalition of partners from across the state from the following organizations: ...

Hoberman said, “This is Trump’s goon squad, for Christ’s sake.” There are no scientific measures of steroid use in law ...

SPARK NS and Haukeland University Hospital today announced they are collaborating on a randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the efficacy of orally administered ...

Our weekly bill tracker gives the rundown of the most consequential bills making movement in the Indiana legislature.

GSK (GSK.L) signed a definitive agreement to purchase US-based clinical-stage biopharmaceutical company Rapt Therapeutics for ...